Clinical Trial Update: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of 2% AN2728 topical ointment in children, adolescents, and adults aged 2 years and older with atopic dermatitis; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AN2728 Topical Ointment 2% (AN2728)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2017-03-06